跳至主要瀏覽功能
EBSCO, research databases, ebooks, discovery service
  • 開始您的研究
  • 解決方案
    • 學術圖書館
      • 為研究人員提供核心研究資料庫、電子期刊及電子書資源。全面管理圖書館技術、採購及館藏發展。
    • 公共圖書館
      • 協助館藏發展與管理,滿足使用者資訊需求,推動終身學習,改變人生軌跡。
    • 中小學校/國際學校
      • 提供可信賴的資源和技術支援,協助學生研究、課程落實及資訊素養技能的提升。
    • 醫學/醫療衛生單位
      • 提供基於實證的解決方案,分享決策資源,同時,提供醫療保健領域的商業智慧和經過同儕評鑑的研究資源。
    • 公司企業
      • 協助員工成長,提升綜合技能,滿足研發需求,實現職場成功。
    • 出版社
      • 擴大您的內容或服務覆蓋範圍,在現有新市場提升佔有率。
    • 研究人員與學生
      • 透過您的機構/組織訪問我們的產品,即刻開啟您的研究之旅。
    • 訪問EBSCOhost
    • 瀏覽產品
    • 聯絡我們
  • 產品與服務
    • 技術與探索服務
      • BiblioGraph
      • EBSCO Discovery Service 探索服務
      • EBSCO FOLIO
      • EBSCO 行動裝置 App
      • EBSCO OpenAthens
      • EBSCOadmin
      • EBSCOhost研究平臺
      • Explora
      • Full Text Finder
      • Panorama
      • Stacks
    • 資料庫和典藏資源
      • 電子檔案
      • Magazine Archives 雜誌典藏檔案
      • 研究型資料庫
    • 臨床決策支援
      • DynaMed
    • 期刊、套裝電子資源以及雜誌
      • 期刊訂閱服務
    • 書籍和電子書館藏
      • EBSCO eBooks
      • EBSCOhost Collection Manager
    • 專業服務
      • EBSCO專業服務
    • 訪問EBSCOhost
    • 瀏覽產品
    • 聯絡我們
  • 深度洞察
    • 探索
      • EBSCOpost Blog
      • 資源中心
    • 連接
      • 活動
      • 電子月報
      • 最新消息
    • 學習
      • 獲得更多支援
      • EBSCO 學會
      • 宣傳資料
      • 收錄內容清單
    • 訪問EBSCOhost
    • 瀏覽產品
    • 聯絡我們
  • 公司
    • 公司簡介
      • 我們的使命
      • 資深管理團隊
      • 全球辦公室
      • 工作機會
    • 承諾與責任
      • 無障礙使用
      • Open Access 開放獲取
      • 人工智能(AI)
    • 價值觀
      • 企業社會責任
      • 我們的員工與社群
      • 減碳政策
      • 信賴與安全
    • 訪問EBSCOhost
    • 瀏覽產品
    • 聯絡我們
  • Čeština
  • Deutsch
  • English
  • Español
  • Français
  • Italiano
  • Nederlands
  • Polski
  • Português
  • Türkçe
  • العربية
  • ประเทศไทย
  • 日本語
  • 简体中文
  • 繁體中文
  • 한글
聯絡我們

正在尋找學術資料開啟研究之旅? 來試試EBSCOhost資料庫吧

DynaMed

  • DynaMed Solutions Overview
  • Products
      • DynaMedex
      • DynaMed
      • DynaMed Decisions
  • Benefits
      • DynaMedex
      • DynaMed
      • DynaMed Decisions
    • Benefits Overview
  • Who We Serve
      • Health Care Organizations
      • Practicing Clinicians
      • Clinicians in Training
      • Biotech & Pharmaceutical Companies
    • Who We Serve Overview
  • About
      • Meet Our Experts
      • Evidence-Based Process
      • Partners
      • Multimedia
      • Health Equity and Inclusion
      • EBM Focus Newsletter
      • Health Notes Blog
      • Press Releases
      • Conflict of Interest Policy
      • What We Publish
      • Testimonials
    • Visit About Page

正在尋找學術資料開啟研究之旅? 來試試EBSCOhost資料庫吧

Newsletter Archives

篩選清單

  • EBM Focus
  • (-)MBE em Foco
  • (-)Resident Focus

  • Clear All Filters
  • (-)MBE em Foco
  • (-)Resident Focus

Showing 81 to 100 of 231 articles.

MBE em foco - Volume 6, Issue 17
Consumir alimentos orgânicos realmente reduz o seu risco de câncer?
Resident Focus - Volume 15, Issue 11
In euthyroid patients with persistent symptoms of Hashimoto thyroiditis on thyroid replacement therapy, total thyroidectomy may improve general health and fatigue compared to medical management
MBE em foco - Volume 6, Issue 16
Pacientes negros podem estar sob risco aumentado de hospitalização e morte por COVID-19
Resident Focus - Volume 15, Issue 10
In patients with heart failure with reduced ejection fraction, dapagliflozin reduces risk of composite of worsening heart failure and cardiovascular death in both patients with or without diabetes
MBE em foco - Volume 6, Issue 15
Programas de bem-estar no local de trabalho parecem ter pouco efeito sobre os desfechos de saúde dos empregados
MBE em foco - Volume 6, Issue 14
Segure a faca - os antibióticos são uma opção razoável para a apendicite em crianças?
Resident Focus - Volume 15, Issue 9
Addition of fenofibrate to statins may reduce composite cardiovascular events in adults with metabolic syndrome
MBE em foco - Volume 6, Issue 13
Cinco coisas que você deveria saber sobre os testes de anticorpos para COVID-19
MBE em foco - Volume 6, Issue 12
Marcadores intermediários na gestação: deveríamos adotar novas diretrizes sugerindo parto cesáreo para HSV no terceiro trimestre?
Resident Focus - Volume 15, Issue 8
Acetazolamide 62.5 mg twice daily may be as effective as standard dose (125 mg twice daily) for reducing the risk of acute mountain sickness
MBE em foco - Volume 6, Issue 11
Tiazidas e câncer de pele? Não se deixe queimar pela hype.
MBE em foco - Volume 6, Issue 10
Repetindo: vacina tríplice viral não aumenta o risco de autismo, mesmo entre crianças de alto risco
Resident Focus - Volume 15, Issue 7
Subthreshold aerobic exercise shortens time to recovery compared to stretching in adolescents with sport-related concussion
MBE em foco - Volume 6, Issue 9
Enfiando a agulha: tPA para AVC ao despertar, ou administrado mais de 4,5 horas após o início dos sintomas, pode melhorar a funcionalidade a 90 dias
MBE em foco - Volume 6, Issue 8
Opiniões de especialistas e evidências de baixa qualidade ainda direcionam a maioria das recomendações fortes em cardiologia
Resident Focus - Volume 15, Issue 6
Intimate partner violence during pregnancy may increase risk of infant perinatal death
Resident Focus - Volume 15, Issue 5
Sacubitril/valsartan might be associated with reduced risk of cardiovascular mortality or hospitalization for heart failure compared to valsartan alone in adults with heart failure with mid-range ejection fraction (45%-57%)
MBE em foco - Volume 6, Issue 7
Não são os inibidores da ECA que estão matando as pessoas com COVID-19
MBE em foco - Volume 6, Issue 6
Canagliflozina para proteção renal: não é um novo inibidor da ECA
MBE em foco - Volume 6, Issue 5
Uma perspectiva da MBE sobre a hidroxicloroquina e a azitromicina para o tratamento da COVID-19
back to top
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Current page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Footer links
    • Twitter
    • LinkedIn
    • Help
    • Privacy Policy
    • Cookie Policy
    • Terms of Use
  • © 2025 EBSCO Information Services. All rights reserved